Angiokeratoma
MONDO:0003143A vascular lesion in the papillary dermis resulting from ectasia of pre-existing vessels. It is associated with secondary proliferative changes in the overlying epidermis (hyperkeratosis). It can present with widespread lesions (angiokeratoma corporis diffusum, often associated with inborn errors of metabolism) or as a localized lesion (angiokeratoma of Fordyce, angiokeratoma circumscriptum, and angiokeratoma of Mibelli).
Also known as: angiokeratoma (morphologic abnormality), angiokeratoma of skin, angiokeratoma of the skin, cutaneous angiokeratoma, skin angiokeratoma
1444 clinical trials for this condition and its sub-types, 2 tagged with Angiokeratoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Angiokeratoma
-
Angiokeratoma circumscriptum 0 trials
-
Angiokeratoma of Fordyce 0 trials
2 sub-types
- Angiokeratoma of scrotum 0 trials
- Vulvar angiokeratoma 0 trials
-
Angiokeratoma of mibelli 0 trials
-
New gel could ease painful skin growths
Disease control Recruiting nowThis phase 2 trial tests a gel called PTX-022 (sirolimus) on people aged 6 and older with angiokeratomas, which are small, raised skin spots. The study will check if the gel is safe and helps improve the appearance of these spots. Fifteen participants will apply the gel and be mo…
Phase 2 • Sponsor: Palvella Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Massive global study aims to unlock fabry disease mysteries
Knowledge-focused Recruiting nowThis study is a long-term registry that collects health information from people with Fabry disease, a rare genetic disorder. It does not test any new treatments; instead, it follows up to 9,000 patients worldwide to better understand how the disease progresses and how current tre…
Sponsor: Genzyme, a Sanofi Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC